Intranasal dexmedetomidine for transthoracic echocardiography in infants with shunt-dependent single ventricle heart disease.
Chalani D EllepolaStephanie S HandlerMichele FrommeltDavid E SaudekJohn ScottGeorge HoffmanPeter C FrommeltPublished in: Cardiology in the young (2022)
Intranasal dexmedetomidine may be a reasonable option for echocardiography sedation in infants with shunt-dependent single ventricle heart disease, and further investigation is warranted to ensure efficacy and safety in an outpatient setting.